ADVERTISEMENT



Google       

Home -> Law Blog Directory -> Legal News Blogs -> Lawyers and Settlements

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Legal News

: Lawyers and Settlements

Raptiva Risks Outweighed Benefits

ADVERTISEMENTS
Washington, DC: On April 8, 2009 Genentech Inc., the manufacturer of Raptiva (efalizumab) announced it has voluntarily withdrawn the psoriasis drug from the US market. The decision is based on the association of Raptiva and PML or progressive multifocal leukoencephalopathy, a rare and usually fatal disease of the central nervous system. Sadly, the withdrawal was not soon enough for three patients who have died from PML after taking Raptiva for more than three years. Another patient treated with Raptiva developed progressive neurologic symptoms and died of unknown cause.

Full post as published by Lawyers and Settlements on April 14, 2009 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Lawsuits and Settlements

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0029 secs (from cache 10/31/26 06:24:06)